Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug
5/22/2013
More...
|
Eli Lilly and Company (LLY) to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial
5/15/2013
More...
|
CytRx Corporation (CYTR) Ditches Lung Cancer Drug After Phase 2 Trial Failure
5/10/2013
More...
|
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns
5/7/2013
More...
|
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy
4/19/2013
More...
|
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt
4/4/2013
More...
|
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML
4/3/2013
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Cancer Drug Fails in Late-Stage Trial; Shares Plunge
3/27/2013
More...
|
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study
3/21/2013
More...
|
Pfizer Inc. (PFE) Halts Development of Hepatitis C Drug
3/19/2013
More...
|
Moberg Derma Discontinues Clinical Development of Limtop
3/11/2013
More...
|
AEterna Zentaris (AEZS) to Discontinue Phase 3 Trial in Multiple Myeloma With Perifosine
3/11/2013
More...
|
FDA Halts Amgen (AMGN) Trial After Teen Death
3/4/2013
More...
|
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug
2/13/2013
More...
|
Eli Lilly and Company (LLY) to Cease Tabalumab Phase 3 RA Program
2/8/2013
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Halts Development of Two Hepatitis C Treatments
2/6/2013
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) to Stop Developing Anti-Depressant
2/1/2013
More...
|
What Merck & Co., Inc. (MRK) Told Doctors About Tredaptive Before It Stopped Selling It
1/15/2013
More...
|
Merck & Co., Inc. (MRK) Pulls Tredaptive Cholesterol Pill After a Flop
1/14/2013
More...
|
Tranzyme Pharma (TZYM) Stops Mid-Stage Gastric Study After Drug Fails
12/18/2012
More...
|
Boehringer Ingelheim Corporation Ends Phase 2 Trial of Dabigatran in Mechanical Valve Patients
12/13/2012
More...
|
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs
12/10/2012
More...
|
Bristol-Myers Squibb Company (BMY) Drops Alzheimer's Drug on Little Benefit
12/5/2012
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor
12/3/2012
More...
|
Merck & Co., Inc. (MRK) Shelves Development of Another Diabetes-Cholesterol Program
11/14/2012
More...
|
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects
11/7/2012
More...
|
Bioniche Life Sciences Inc. (BNC) Discontinues Current Phase 3 Clinical Trial With Urocidin™
11/5/2012
More...
|
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program
10/29/2012
More...
|
Abbott Laboratories (ABT), Reata Pharmaceuticals, Inc. Kidney Disease Drug Trial Stopped
10/22/2012
More...
|
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt
10/12/2012
More...
|
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study
10/11/2012
More...
|
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic
10/8/2012
More...
|
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial
10/3/2012
More...
|
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug
10/2/2012
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Ends Work on One Hepatitis C Drug, Continues Another
9/26/2012
More...
|
Astex Pharmaceuticals (ASTX) Ends Development of Lung Cancer Drug
9/24/2012
More...
|
Targacept, Inc. (TRGT) to Cut More Jobs, Halt ADHD Drug Development After Failed Phase 2 Trial
9/18/2012
More...
|
Johnson & Johnson (JNJ) Ends Trial of Skin-Disorder Drug Over Adverse Events
9/17/2012
More...
|
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems
9/17/2012
More...
|
Geron Corporation (GERN) Ends Breast Cancer Study of Imetelstat
9/11/2012
More...
|
Zalicus Inc. (ZLCS) to Halt Further Clinical Development With Synavive
9/10/2012
More...
|
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug
9/10/2012
More...
|
Eli Lilly and Company (LLY) Ends Development of Schizophrenia Drug
8/30/2012
More...
|
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss
8/27/2012
More...
|
Gilead Sciences, Inc. (GILD) Stops Development of PAH Drug After Missing Study Goal
8/23/2012
More...
|
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Scrap Alzheimer's Drug After Phase III Study Fails
8/8/2012
More...
|
Infinity Pharmaceuticals Inc. (INFI) Pulls Plug on Cancer Drug Saridegib Trials
6/19/2012
More...
|
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped
6/5/2012
More...
|
Chelsea Therapeutics, Inc. (CHTP) Halts Development of Arthritis Drug
6/1/2012
More...
|
Q-Med AB Discontinues the Breast Indication for Macrolane
4/17/2012
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Discontinue Development of SCV-07 Oral Mucositis Trial
3/7/2012
More...
|
Karo Bio AB Axes Clinical Dyslipidemia Program After Side Effects Surface in Animal Study
2/15/2012
More...
|
Theratechnologies Inc. (TH.TO) Cuts 60% of Workforce, Refocus for 2013
12/7/2011
More...
|
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox
12/5/2011
More...
|
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study
11/29/2011
More...
|
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer
11/28/2011
More...
|
Moberg Derma Discontinues Preclinical Development Program for A-Fizz
10/27/2011
More...
|
Conatus Pharmaceuticals Inc.Terminates Phase 2 Clinical Trial of CTS-1027
10/27/2011
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug
10/10/2011
More...
|
Sangamo BioSciences, Inc. (SGMO) Shares Plunge on Diabetic Neuropathy Drug Failure, to Terminate Development
10/4/2011
More...
|
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug
9/29/2011
More...
|
FDA Issues Clinical Hold on Cancer Drug by Immunomedics, Inc. (IMMU)
9/26/2011
More...
|
Eisai Inc. (ESALF.PK) Discontinues Global Development of Rabeprazole Sodium Extended-Release Capsules, 50 mg
9/6/2011
More...
|
Shire plc Falls After Scrapping Dermagraft as Leg Ulcer Therapy
8/25/2011
More...
|
Endo Pharmaceuticals (ENDP) Terminates Pain Program After Failed Trial; Ends Pact With Grunenthal GmbH
8/19/2011
More...
|
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program
8/8/2011
More...
|
Merck & Co., Inc. (MRK) to Cut Up to 13,000 Jobs, Q2 Profit Rises; Discontinues Ph3 Migraine Program
8/4/2011
More...
|
BeiLu Pharma Gives Up on Melatonin-based Depression Drug
7/19/2011
More...
|
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab
6/28/2011
More...
|
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product
6/24/2011
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Ditches PEG-SN38 for mCRC but Continues Development in Other Cancers
5/19/2011
More...
|
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine
5/5/2011
More...
|
Pfizer Inc. (PFE) Stops Making Canine Tick Med Over Side Effects
4/25/2011
More...
|
Galapagos NV (GLPG.BR) Discontinues Phase II Trial for GLPG0259, Focuses Resources on Other Rheumatoid Arthritis Programs
4/15/2011
More...
|
StemCells Inc. (STEM) Discontinues Batten Disease Program
4/8/2011
More...
|
AstraZeneca PLC (AZN) Pulls Bloodthinner In France
3/24/2011
More...
|
AstraZeneca PLC (AZN) Pulls Asthma Product, Hitting SkyePharma Inc. (SKYE)
3/7/2011
More...
|
Innate Pharma Drops IPH 1101 Development
3/4/2011
More...
|
Pfizer Inc. (PFE) Drops 15 Pipeline Projects
3/1/2011
More...
|
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries
2/15/2011
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Cancels Hepatitis C Drug On Toxicity Worries; Shares Fall
2/10/2011
More...
|
Hospira, Inc. (HSP) to Stop Making Drug Used in Executions
1/24/2011
More...
|
Genentech (RHHBY) Informs Customers of Important Information About Triad Group's Alcohol Prep Pads
1/14/2011
More...
|
More Evidence Links Roche (RHHBY)'s Avastin to Heart Failure in Breast Cancer Patients
1/6/2011
More...
|
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations
12/15/2010
More...
|
Servier's Diabetes Drug, Mediator May Be Linked to 500 Deaths
11/16/2010
More...
|
Transition Therapeutics Inc. (TTH.TO) and Eli Lilly and Company (LLY) Stops Diabetes Drug Development
9/17/2010
More...
|
Basilea Pharmaceutica (BSLN.SW) Announces Discontinuation of Sale of Ceftobiprole by Janssen-Cilag AG, a Johnson & Johnson (JNJ) Company, In Switzerland
9/9/2010
More...
|
Karo Bio AB Announces That Merck & Co., Inc. (MRK) Discontinues Development of Mk-6913 for Hot Flashes
9/8/2010
More...
|
Shire Pharmaceuticals (SHPGY) to Pull Low Blood Pressure Drug from Market
8/18/2010
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Lays Off 70 as Propofol is Abandoned
8/16/2010
More...
|
Pfizer Inc. (PFE) Pulls Leukemia Drug Mylotarg From U.S. Market After Deaths, No Proven Benefit
6/22/2010
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Says Pfizer Inc. (PFE) to Stop Development of Arthritis Drug, TRU-015
6/15/2010
More...
|
Teva Pharmaceutical Industries Limited (TEVA) To Stop Manufacturing Propofol Sedative
5/28/2010
More...
|
FDA Says Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available
4/14/2010
More...
|
GenVec Inc. (GNVC) Says Cancer Drug Not Effective, Ends Trial
3/30/2010
More...
|
Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints Not Met in Phase 3 Trial
3/18/2010
More...
|
Pfizer Inc. (PFE) (JOBS) Drops 100 Drugs from Pipeline
1/29/2010
More...
|
Pfizer Inc. (PFE) (JOBS) Ends Late-stage Lung-Cancer Study; Analysis Showed it Would Miss Main Goal
12/30/2009
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Announces Merck KGaA (MKGAF.PK) Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
12/28/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Stops Development of Two Drugs: Eplivanserin in Insomnia and Thrombosis Drug Idrabiotaparinux
12/21/2009
More...
|
BioMS Medical (MS.TO) Provides Corporate Update; Company will Not Pursue Further Late Stage Clinical Trials with Dirucotide in MS
12/18/2009
More...
|
Thallion Pharmaceuticals Inc. Discontinues Phase II Glioblastoma Multiforme Trial After Review of Interim Data
12/18/2009
More...
|
Seattle Genetics, Inc. (SGEN) (JOBS) Stops Mid-Stage Cancer Trial
10/6/2009
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) (JOBS) Drops Cancer Drug Development
10/5/2009
More...
|
ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials
9/29/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) Abandons One Migraine Drug MK-3207, Pursues Another
9/11/2009
More...
|
Antisoma PLC (ASM.L) Announces Discontinuation of Development of AS1402
8/10/2009
More...
|
Insmed Incorporated (INSM) Stops Supplying Iplex To New Patients
7/27/2009
More...
|
Repros Therapeutics Inc. (RPRX) to Stop Using 50 mg Dose in Fibroids Study
7/1/2009
More...
|
UCB Group (UCBJF.PK) and Biogen Idec, Inc. (Massachusetts) (BIIB) Discontinue Phase II Clinical Trial of CDP323
7/1/2009
More...
|
Roche Holding AG (RHHBF.PK) Stops Selling Acne Drug Accutane
6/30/2009
More...
|
ImmunoGen, Inc. (IMGN) to End Stomach-Cancer Drug Development
6/15/2009
More...
|
Halozyme Therapeutics, Inc. (HALO) Not to Develop Osteoporosis Study Further
6/5/2009
More...
|
Pfizer Inc. (PFE) (JOBS) Discontinues Late-stage Trial of Sunitinib in Advanced Breast Cancer
6/3/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15%
4/29/2009
More...
|
Targacept, Inc. (TRGT) Provides Update on TC-6499 and Pain Program in GlaxoSmithKline (GSK) Alliance - Data Does Not Support Further Development
3/11/2009
More...
|
Pfizer Inc. (PFE) Drops Development of 2 Late-Stage Drugs
2/24/2009
More...
|
Enzon Pharmaceuticals, Inc. (ENZN) Discontinues Further Development of rhMBL
2/10/2009
More...
|
Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
1/29/2009
More...
|
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy
1/22/2009
More...
|
Nile Therapeutics, Inc. Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program
1/20/2009
More...
|
Neurobiological Technologies, Inc. (NTII) Ends Stroke Drug Development; Cuts Jobs
1/13/2009
More...
|
EpiCept Corporation (EPCT) Discontinues Drug Discovery Operations and Reduces Workforce
1/12/2009
More...
|
Avigen, Inc. (AVGN) Stops Development of Lead Drug; Reduces Headcount by 70%
12/22/2008
More...
|
SkyePharma Inc. (SKYE) Ceases Commercialization of formoterol Certihaler(R) in the United States
12/19/2008
More...
|
Adolor Corporation (ADLR) to Stop Development of Bowel Dysfunction Drug
12/18/2008
More...
|
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound
11/17/2008
More...
|
Pfizer Inc. (PFE) (JOBS) Ends Development of Obesity Drug
11/6/2008
More...
|
Sanofi-Aventis (France) (SASY.PA) Ends Research on Troubled Diet Drug, Accomplia
11/6/2008
More...
|
Mayo Clinic Cuts Clinical Trial Services Business; Jobs Affected
11/6/2008
More...
|
ZymoGenetics, Inc. (ZGEN) Kidney Disease Drug Study Stopped
10/28/2008
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) To Discontinue Rheumatoid Arthritis Drug As Drug Fails To Meet Primary, Secondary Endpoints
10/10/2008
More...
|
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts
10/8/2008
More...
|
Life Science Weekly inSite (Sep. 29 - Oct. 3)
10/6/2008
More...
|
Merck & Co., Inc. (MRK) (JOBS) Discontinues Development of Investigational Medicine Taranabant for Obesity
10/2/2008
More...
|
Most Failed Clinical Trials Are Never Published
9/23/2008
More...
|
Valens Pharma Ltd. Announces Next Steps; Company Has Suspended Work on its DCA i.v Program
8/6/2008
More...
|
EMD Serono, Inc. to Discontinue Geref Diagnostic
8/5/2008
More...
|
Ambrilia Biopharma Inc. Provides Update on PPL-100; Merck & Co., Inc. (MRK) (JOBS) Places Development Hold on Drug
7/28/2008
More...
|
Progen Pharmaceuticals Limited (PGLA) Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
7/24/2008
More...
|
MethylGene and Celgene (CELG) Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials
7/23/2008
More...
|
National Institute of Allergy And Infectious Diseases (NIAID) Will Not Move Forward with the PAVE 100 HIV Vaccine Trial
7/18/2008
More...
|
Jury Finds Johnson & Johnson (JNJ) (JOBS) Not Liable in Motrin Lawsuit
7/18/2008
More...
|
DUSA Pharmaceuticals (DUSA) Announces Update on Nicomide(R); Company Places Voluntary Hold on Existing Inventory
7/18/2008
More...
|
Infinity Pharmaceuticals, Inc. Discontinues Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer
7/16/2008
More...
|
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer
7/16/2008
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
7/1/2008
More...
|
Novexel Discontinues Development of NXL 101
6/30/2008
More...
|
Gene-testing Firms Under Fire
6/16/2008
More...
|
Novo Nordisk A/S (NVO) Discontinues Phase 3 Clinical Trial with NovoSeven(R) in Trauma
6/11/2008
More...
|
AVI BioPharma, Inc. (AVII) Provides Update on New Business Plan: Discontinues Drug Program, Cuts Jobs
6/10/2008
More...
|
EXACT Sciences Corporation (EXAS) Reports on Laboratory Corporation of America Holdings (LH)'s Plans to Launch a New Laboratory-developed Stool-based DNA Screening Test for Colorectal Cancer in 2008; LabCorp Stopped Offering PreGen-Plus
6/5/2008
More...
|
Merck & Co., Inc. (MRK) Ends Study of Cholesterol Drug
5/21/2008
More...
|
Dynavax Technologies Corporation (DVAX) Ends Development Of Allergy Drug Tolamba After Trial Failure
5/16/2008
More...
|
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials
5/13/2008
More...
|
SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results
5/13/2008
More...
|
King Pharmaceuticals®, Inc. Announces Tilade Inhaler to be Discontinued
5/2/2008
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Management Realignment and R&D Portfolio Change; Discontinued Development of NPI 32101 for Inflammatory Bowel Disease (IBD)
5/1/2008
More...
|
Replidyne, Inc. (RDYN) Discontinues Phase III Trial to Conserve Cash
4/23/2008
More...
|
Inspire Pharmaceuticals, Inc. (ISPH) to Discontinue Development of Epinastine Nasal Spray
4/23/2008
More...
|
Synexus' AstraZeneca PLC (AZN)'s Crestor Jupiter Study Stopped Early
4/18/2008
More...
|
Elan Corporation PLC (ELN), Wyeth (WYE) Suspend Alzheimer's Vaccine Study
4/18/2008
More...
|
ViroPharma Incorporated (VPHM) and Wyeth Pharmaceuticals End Development of Hepatitis C Drug
4/17/2008
More...
|
Eisai Company, Ltd. (ESALY.PK) to Drop E2007 Development for Parkinson's Disease
4/11/2008
More...
|
ArQule, Inc. (ARQL) Provides Clinical Update on E2F-1 Program; Company Plans to Stop Further Clinical Testing
4/10/2008
More...
|
Pfizer Inc. (PFE) Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma
4/2/2008
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Says to Drop Development of Cholesterol Drug
3/28/2008
More...
|
Keryx Biopharmaceuticals (KERX) Announces Termination of SUN-MACRO Phase 4 Trial
3/28/2008
More...
|
Sonus Pharmaceuticals, Inc. (SNUS) Ends Discovery Efforts of Two Programs and Reduces its Headcount
3/25/2008
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) to Stop Clinical Development of Depression Drug
3/20/2008
More...
|
Nuvelo, Inc. (NUVO) Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
3/18/2008
More...
|
Genitope Corporation (GTOP) Stops Cancer Vaccine Program, Looking at Finances
3/11/2008
More...
|
Alkermes (ALKS) Receives Notice from Eli Lilly and Company (LLY) Terminating Inhaled Insulin Program
3/7/2008
More...
|
Alkermes (ALKS) Provides Update on Inhaled Insulin Program; Eli Lilly and Company (LLY) Expected to Discontinue the Program
3/7/2008
More...
|
Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Inc., Announces the Discontinuation of the Development Program for Pafuramidine
2/25/2008
More...
|
Baxter International, Inc. (BAX) Halts Heparin Production Amid Reactions
2/12/2008
More...
|
Eli Lilly and Company (LLY) Announces Discontinuation of Humatin (Paromomycin Sulfate Capsules, USP)
2/8/2008
More...
|
Neose Technologies, Inc. (NTEC) Announces Discontinuation of NE-180 Program; Job Cuts
1/30/2008
More...
|
NMT Medical, Inc (NMTI) Terminates Further Enrollment in MIST II
1/23/2008
More...
|
Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
1/23/2008
More...
|
Unfavorable Drug Studies Don't Get Into Print: Report
1/17/2008
More...
|
NitroMed, Inc. (NTMD) Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options
1/16/2008
More...
|
Novacea, Inc. (NOVC) to Discontinue Cancer Drug Trial
1/3/2008
More...
|
AstraZeneca LP (AZN) Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets
12/28/2007
More...
|
Hospira, Inc. (HSP) Discontinues 5% Alcohol in 5% Dextrose Injection Drug Product
12/28/2007
More...
|
Discontinued Drug Helps Ulcerative Colitis
12/20/2007
More...
|
Bayer HealthCare Pharmaceuticals (BAY) Marketing of Viadur(R) to Phase Out by April 2008
12/20/2007
More...
|
DEA Suspends a Cardinal Health, Inc. (CAH) Substance-Control License
11/30/2007
More...
|
U.S. Seizes Discontinued Eyelash Product, Harm Vision
11/19/2007
More...
|
Merck & Co., Inc. (MRK) Tells AIDS Vaccine Volunteers Who Got Jab
11/14/2007
More...
|
AtheroGenics (AGIX) Halts High Dose of AGI-1067
11/12/2007
More...
|
King Pharmaceuticals®, Inc. Announces the Discontinuation of Procanbid (R)
11/9/2007
More...
|
Neurochem, Inc. (NRMX) Shifts Focus on Alzheimer's Treatment
11/8/2007
More...
|
Cancelled Merck & Co., Inc. (MRK) Vaccine May Have Boosted HIV Risk
11/8/2007
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) to Discontinue Enrollment in Late-Stage CoFactor Trial
11/2/2007
More...
|
CuraGen Corporation (CRGN) to Stop Development of Oral Mucositis Drug Candidate
10/11/2007
More...
|
Merck & Co., Inc. (MRK) (Jobs) Halts Study of "Ineffective" HIV Vaccine
9/24/2007
More...
|
GeoVax Labs Inc. (GOVX.OB) Comments on Discontinuance of Merck & Co., Inc. (MRK)'s HIV Vaccine Trial
9/24/2007
More...
|
Karo Bio AB Development of Clinical Candidate LXR-623 Discontinued
9/20/2007
More...
|